Abstract:
With high incidence, high morality and high rate of advanced stage patients, hepatocellular carcinoma (HCC) seriously threatening the health of people in China. Early detection and treatment of HCC, through screening for high-risk populations, is instrumental for improved survival of HCC patients in China. Liver resection, local ablation, interventional therapy, radiotherapy and systemic therapy are all effective treatments for HCC patients and appropriate treatments could be selected according to different tumor stages. However, the condition of HCC patients in China is complicated and no single specialty offers the complete spectrum of care. The disease-centered multidisciplinary team (MDT) of HCC is an important method to prolong the survival of HCC patients and maximally improve their quality of life. In recent years, the advances in different disciplines have brought new opportunities in HCC treatments and altered the multidisciplinary managements. Meanwhile, new challenges have also been brought and there are still many problems to be solved.
下载:
